SeaStar Medical also markets a pediatric version of the device, QUELIMMUNE™, for children with AKI and sepsis, which was approved by the FDA earlier this year under a Humanitarian Device Exemption.

“The pace of enrollment in our NEUTRALIZE-AKI trial has quickly accelerated, with 14 new subjects enrolled in slightly more than six weeks,” said Kevin Chung, MD, Chief Medical Officer of ...

SeaStar Medical is progressing its pivotal trial evaluating the use of its Selective Cytopheretic Device (SCD) in patients with acute kidney injury (AKI), with the company announcing that 12 ...

Schneider, J., Khemani, R., Grushkin, C. & Bart, R. Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the ...

Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population.

Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.

Drug-induced AKI (acute kidney injury) is common and may include medications not previously known to exhibit this safety signal.

SeaStar Medical (ICU) announces the activation of Sentara Norfolk General Hospital in Norfolk, Virginia as its thirteenth active site in its ...